Developer of immunotherapeutic vaccines and targeted therapies designed to control tumor growth and recurrence. The company's vaccines use surviving-targeting technology to target a cell-survival prot...

Healthcare
Buffalo, NY, United States
Founded 2012
3 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$21.3M
Last Round
N/A

Get the full picture

Create a free account to unlock MimiVax's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required